> **Historical review artifact - not validation evidence.** This document is a critique/planning transcript only. It is not source extraction evidence, not reference-software parity evidence, not certification evidence, not clinical guidance, and not proof of superiority. Treat all numerical, clinical, guideline, and publication-status statements below as hypotheses unless they are backed by machine-verifiable artifacts in this repository.
# Hardcore Methodological Review (Round 26): The Methodological Horizon

This document registers the transcript of the twenty-sixth-round multiperson adversarial review, debating whether coding more cardiology NMAs provides value compared to introducing new mathematical methods, and outlining the next three methodological frontiers.

### Panel Members:
1.  **Dr. Fiona Vance (The Frequentist Purist)**
2.  **Dr. Benjamin MCMC (The Bayesian Pragmatist)**
3.  **Dr. Cynthia Registry (The Clinical Trialist / ct.gov Data Engineer)**

---

## 1. Practice Trials vs. New Methods: Strategic Verdict

**Dr. Cynthia Registry:**
> "We have already mapped and audited **40 major cardiology trial networks**. Coding more trials will only confirm what we already know: standard NMAs suffer from Time Zero selection bias, zero-event cell distortions, and sample size dominance. 
> 
> Doing more practice runs will not make us better. **True improvement lies in introducing new mathematical and causal methods** that solve these underlying statistical boundaries."

---

## 2. Three Next-Generation Methodological Frontiers

The panel outlines three cutting-edge methodologies from other fields that can directly improve our evidence synthesis engine:

### 2.1. Symbolic Regression for Explainable Non-Proportional Hazards
*   **Source Field:** Explainable AI (XAI) / Mathematical Physics.
*   **The Concept:** Instead of forcing time-varying hazards into a pre-defined fractional polynomial form ($\beta_1 t^{-0.5} + \beta_2 t^2$), we use **Symbolic Regression** (via genetic programming) to search the space of mathematical operators. The engine discovers the *exact closed-form hazard function* representing the treatment effect over time, letting the data define the mathematical shape of the hazard without human preconceptions.

### 2.2. Conditional GANs (cGANs) for Physiological Patient Reconstruction
*   **Source Field:** Generative Deep Learning.
*   **The Concept:** Instead of using a VAE to generate independent synthetic covariates matching trial-level means and SDs, we train a **cGAN** on large, open-access cardiovascular patient databases (like NHLBI BioLINCC repositories). The generator outputs synthetic patient records, while the discriminator ensures that the **joint correlations between covariates** (e.g. the non-linear relationship between age, renal function, and LVEF) match real human physiology. This provides highly realistic covariate matrices for double-robust TMLE.

### 2.3. Bayesian Model Averaging (BMA) for Network Consistency
*   **Source Field:** Econometrics.
*   **The Concept:** In network meta-analyses, the consistency assumption (direct evidence = indirect evidence) can break down due to transitivity violations. Instead of simple node-splitting tests, we implement **BMA** to average treatment rankings over all possible sub-graph structures, weighting each sub-graph by its posterior probability. This helps avoid a single inconsistent trial distorting the final rankings.
